FDA gives thumbs up to Pfizer kidney cancer drug
30 January 2012
Donna Young
Please Login to read the full article.
30 January 2012
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA reviewers question efficacy of Pfizer's kidney cancer drug ahead of ODAC
- Pfizer's Torisel fails in Phase III second-line kidney cancer trial
- AVEO/Astellas 2012 filing for tivozanib as it beats Nexavar in Ph III kidney cancer trial
- NICE plans appraisal for Pfizer's Inlyta in RCC where others have failed
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
